CLDX logo

Celldex Therapeutics (CLDX)

Profile

Full Name

Celldex Therapeutics, Inc.

Ticker Symbol

CLDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 15, 1986

Indexes

Not included

Website

http://www.celldex.com

Employees

186

Key Details

Price

$18.30(+2.81%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.02M(+1.99% YoY)

Annual EPS

-$2.45(+16.10% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$18.30
CLDX price is $18.30

30-Day Relative Volume

0.51
CLDX 30-day relative volume is 0.51

Price Performance

Price Most recent change

+2.81%
CLDX price was up +2.81% on Apr 17, 2025

Price YTD change

-27.58%
CLDX price is down -27.58% since January 1st

Price 1-year change

-53.82%
CLDX price is down -53.82% year-on-year

Price 3-year change

-48.94%
CLDX price is down -48.94% over the past 3 years

Price Range

Price All-time high

$3375.00
CLDX price is currently -99.46% below its historical high of $3375.00

Price 3-year low

$14.40
CLDX price is currently +27.08% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.21B
CLDX market capitalization is $1.21 billion

Market cap 3-year change

-27.5%
CLDX market capitalization is down -27.5% over the past 3 years

Market cap All-time high

$3.29B
CLDX market capitalization is currently -63.03% below its historical high of $3.29 billion

Market cap sector rank

78.52%
CLDX market capitalization is higher than 78.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.72%
CLDX shares outstanding is up +0.72% year-on-year

Shares Outstanding 3-Year Change

+41.98%
CLDX shares outstanding is up +41.98% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.97
CLDX beta is 0.97

200-day SMA

$28.49
CLDX price is currently -35.77% below its 200-day simple moving average

50-day SMA

$19.87
CLDX price is currently -7.90% below its 50-day simple moving average

RSI

49.58
CLDX 14-day relative strength index is 49.58

Volume

0.51
CLDX 30-day relative volume is 0.51

ATR

$1.23
CLDX average true range is $1.23

10-day Historical Volatility

82.67%
CLDX 10-day historical volatility is 82.67%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.02M
CLDX annual revenue is $7.02 million

Revenue Analysts estimate

$4.40M
CLDX annual revenue is currently +59.47% higher than the consensus analysts' forecast

Revenue 1-year change

+1.99%
CLDX annual revenue is up +1.99% year-on-year

Revenue Sector rank

23.88%
CLDX annual revenue is higher than 23.88% of companies in Healthcare sector

EPS

EPS

-$2.45
CLDX annual earnings per share is -$2.45

EPS Analysts estimate

-$3.27
CLDX annual earnings per share is currently -24.97% lower than the consensus analysts' forecast

EPS 1-year change

+16.1%
CLDX annual earnings per share is up +16.1% year-on-year

EPS Sector rank

34.13%
CLDX annual earnings per share is higher than 34.13% of companies in Healthcare sector

Profit

Gross profit

-
CLDX annual gross profit value is unknown

Gross margin

-
CLDX annual gross profit margin value is unknown

Operating profit

-$195.08M
CLDX annual operating income is -$195.08 million

Operating margin

-2778.89%
CLDX annual operating profit margin is -2778.89%

Net income

-$157.86M
CLDX annual net profit is -$157.86 million

Net margin

-2248.76%
CLDX annual net profit margin is -2248.76%

Expenses

Total expenses

$202.10M
CLDX annual total expenses is $202.10 million

Operating expenses

$202.10M
CLDX annual total operating expenses is $202.10 million

Cost of goods sold

-
CLDX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$38.55M
CLDX annual SGA is $38.55 million

Depreciation and amortization

$3.18M
CLDX annual depreciation & amortization is $3.18 million

Interest expense

-
CLDX annual interest expense value is unknown

Income tax

-
CLDX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$195.08M
CLDX annual earnings before interest & taxes is -$195.08 million

EBITDA

-$191.90M
CLDX annual EBITDA is -$191.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$792.34M
CLDX annual total assets is $792.34 million

Non current assets

$45.18M
CLDX annual long term assets is $45.18 million

Current assets

$747.16M
CLDX annual total current assets is $747.16 million

Cash and cash equivalents

$28.36M
CLDX annual cash & cash equivalents is $28.36 million

Accounts receivable

$700.00K
CLDX annual accounts receivable is $700.00 thousand

Inventory

-
CLDX annual inventory value is unknown

Liabilities

Total liabilities

$45.34M
CLDX annual total liabilities is $45.34 million

Long term liabilities

$5.83M
CLDX annual total long term liabilities is $5.83 million

Current liabilities

$39.50M
CLDX annual total current liabilities is $39.50 million

Accounts payable

$3.27M
CLDX annual accounts payable is $3.27 million

Debt

Total debt

$3.81M
CLDX annual total debt is $3.81 million

Total debt 1-year change

+50%
CLDX annual total debt is up +50% year-on-year

Long term debt

$2.36M
CLDX annual long term debt is $2.36 million

Short term debt

$1.45M
CLDX annual short term debt is $1.45 million

Equity & Capital

Shareholders equity

$747.00M
CLDX annual stockholders equity is $747.00 million

Book value

$747.00M
CLDX annual book value is $747.00 million

Retained earnings

-$1.56B
CLDX annual retained earnings is -$1.56 billion

Working capital

$707.66M
CLDX annual working capital is $707.66 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$157.78M
CLDX annual cash flow from operations is -$157.78 million

Cash from operations 1-year change

-47.06%
CLDX annual cash flow from operations is down -47.06% year-on-year

Cash from investing

-$290.13M
CLDX annual cash flow from investing activities is -$290.13 million

Cash from investing 1-year change

-174.27%
CLDX annual cash flow from investing activities is down -174.27% year-on-year

Cash from financing

$441.45M
CLDX annual cash flow from financing activities is $441.45 million

Cash from financing 1-year change

+102.07%
CLDX annual cash flow from financing activities is up +102.07% year-on-year

CAPEX

CAPEX

$1.92M
CLDX annual capital expenditures is $1.92 million

CAPEX 1-year change

+5.56%
CLDX annual capital expenditures is up +5.56% year-on-year

Free Cash Flow

Free cash flow

-$159.70M
CLDX annual free cash flow is -$159.70 million

Free cash flow 1-year change

-46.36%
CLDX annual free cash flow is down -46.36% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CLDX annual gross profit margin value is unknown

Operating margin

-2778.89%
CLDX annual operating profit margin is -2778.89%

Net margin

-2248.76%
CLDX annual net profit margin is -2248.76%

ROA & ROE

ROA

-25.10%
CLDX annual return on assets is -25.10%

ROE

-26.84%
CLDX annual return on equity is -26.84%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CLDX price to earnings ratio value is unknown

PE ratio Sector rank

-
CLDX price to earnings ratio is unknown

PB Ratio

PB ratio

1.63
CLDX price to book ratio is 1.63

PB ratio Sector rank

57.63%
CLDX price to book ratio is higher than 57.63% of companies in Healthcare sector

PS Ratio

PS ratio

173.05
CLDX price to sales ratio is 173.05

PS ratio Sector rank

96.41%
CLDX price to sales ratio is higher than 96.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.19B
CLDX enterprise value is $1.19 billion

Enterprise value Sector rank

76.86%
CLDX enterprise value is higher than 76.86% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-6.20
CLDX EV/EBITDA is -6.20

EV/EBITDA Sector rank

16.36%
CLDX EV/EBITDA is higher than 16.36% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

18.91
CLDX annual current ratio is 18.91

Quick ratio

-
CLDX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CLDX annual debt to equity ratio is 0.00

Interest coverage ratio

-
CLDX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CLDX piotroski f-score value is unknown

Altman Z-Score

13.60
CLDX altman z-score is 13.60

Analyst ratings

Recent major analysts updates

Mar 20, 25 Morgan Stanley
Overweight
Mar 3, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Goldman Sachs
Neutral
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 13, 25 UBS
Buy
Jan 2, 25 Cantor Fitzgerald
Overweight
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 19, 24 HC Wainwright & Co.
Buy
Nov 20, 24 HC Wainwright & Co.
Buy
Nov 7, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IART logo
Integra LifeSciences Holdings (IART)
NEO logo
NeoGenomics (NEO)
TDOC logo
Teladoc Health (TDOC)
PLSE logo
Pulse Biosciences (PLSE)
GPCR logo
Structure Therapeutics (GPCR)
BKD logo
Brookdale Senior Living (BKD)
LQDA logo
Liquidia (LQDA)
Kestra Medical Technologies (KMTS)
OCUL logo
Ocular Therapeutix (OCUL)
  • What is the ticker symbol for Celldex Therapeutics?
  • Does Celldex Therapeutics pay dividends?
  • What sector is Celldex Therapeutics in?
  • What industry is Celldex Therapeutics in?
  • What country is Celldex Therapeutics based in?
  • When did Celldex Therapeutics go public?
  • Is Celldex Therapeutics in the S&P 500?
  • Is Celldex Therapeutics in the NASDAQ 100?
  • Is Celldex Therapeutics in the Dow Jones?
  • When was Celldex Therapeutics's last earnings report?
  • When does Celldex Therapeutics report earnings?
  • Should I buy Celldex Therapeutics stock now?

What is the ticker symbol for Celldex Therapeutics?

The ticker symbol for Celldex Therapeutics is NASDAQ:CLDX

Does Celldex Therapeutics pay dividends?

No, Celldex Therapeutics does not pay dividends

What sector is Celldex Therapeutics in?

Celldex Therapeutics is in the Healthcare sector

What industry is Celldex Therapeutics in?

Celldex Therapeutics is in the Biotechnology industry

What country is Celldex Therapeutics based in?

Celldex Therapeutics is headquartered in United States

When did Celldex Therapeutics go public?

Celldex Therapeutics's initial public offering (IPO) was on May 15, 1986

Is Celldex Therapeutics in the S&P 500?

No, Celldex Therapeutics is not included in the S&P 500 index

Is Celldex Therapeutics in the NASDAQ 100?

No, Celldex Therapeutics is not included in the NASDAQ 100 index

Is Celldex Therapeutics in the Dow Jones?

No, Celldex Therapeutics is not included in the Dow Jones index

When was Celldex Therapeutics's last earnings report?

Celldex Therapeutics's most recent earnings report was on Feb 27, 2025

When does Celldex Therapeutics report earnings?

The next expected earnings date for Celldex Therapeutics is May 6, 2025

Should I buy Celldex Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page